À Propos de l'Entreprise
- Raison sociale: Yaohai Biotechnology (Beijing) Co.,Ltd
- Pays d'enregistrement: China
- Adresse: 4th Floor, Building 1, Zhongguan Science and Technology Park, No.25 Yongxing Road, Daxing District, Beijing
- Nombre d'employés: 250 - 499
- Année de création: 2010
Description:
As a CRTDMO (Contract Research, Testing, Development and Manufacturing Organization) focused on microbial expression systems, Yaohai provides one-stop, end-to-end biopharmaceutical services including manufacturing recombinant proteins, peptides/polypeptides, enzymes, antibody fragments, plasmid DNA and mRNA. The company also provides long (IVT) RNA production services, operating a cGMP production platform with fermentation scale exceeding 7,500L, making it the largest GMP-level plasmid supplier in China, capable of meeting clinical and commercial needs.
Activités Commerciales
Services de sous-traitance & d’externalisation
Organisation de Développement et Fabrication sous Contrat (CDMO)FabricantFabricant sous Contrat (CMO)
Extraits Naturels & Ingrédients Botaniques
FabricantFabricant sous Contrat (CMO)
Services de Conditionnement à Façon
FabricantFabricant sous Contrat (CMO)
Classification ATC (Anatomique, Thérapeutique, Chimique)
FabricantFabricant sous Contrat (CMO)
API de Référence (Princeps)
FabricantFabricant sous Contrat (CMO)
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman
Produits/Services Clés
- Services de sous-traitance & d’externalisation: Biosimilars, vaccines and diagnostics CRDMO for human and veterinary use, Biological therapeutics CRDMO
- Produits Biopharmaceutiques: Recombinant protein/mRNA CDMO services, Novel recombinant vaccines
- Services Biopharmaceutiques: Aesthetic medicine CMO / Ingredient Supply: Collagen, BTX;GLP-1 / semaglutide / Liraglutide: CMO / Ingredient Supply;Agrochemicals CMO;
Nos Produits & Services
Sell · Biopharmaceutical Services
Certifications
EU QP audited
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire